Article
De Novo Biosynthesis of Vindoline and Catharanthine in Saccharomyces cerevisiae
1 Jan 2022
Abstract excerpt
Vinblastine has been used clinically as one of the most potent therapeutics for the treatment of several types of cancer. However, the traditional plant extraction method suffers from unreliable supply, low abundance, and extremely high cost. Here, we use synthetic biology approach to engineer Saccharomyces cerevisiae for de novo biosynthesis of vindoline and catharanthine, which can be coupled chemically or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
